Michael A Bachelor1, Yan Lu, David M Owens. 1. Department of Dermatology, Columbia University, College of Physicians and Surgeons, New York, NY 10032, USA.
Abstract
BACKGROUND: L-3-Phosphoserine phosphatase (PSPH) is a highly conserved and widely expressed member of the haloacid dehalogenase superfamily and the rate-limiting enzyme in l-serine biosynthesis. We previously found Psph expression to be uniquely upregulated in a α6β4 integrin transgenic mouse model that is predisposed to epidermal hyperproliferation and squamous cell carcinoma (SCC) formation implicating a role for Psph in epidermal homeostasis. OBJECTIVE: We examined the status of PSPH in normal skin epidermis and skin tumors along with its sub-cellular localization in epidermal keratinocytes and its requirement for squamous cell carcinoma (SCC) proliferation. METHODS: First, an immunohistochemical study was performed for PSPH in normal skin and skin cancer specimens and in cultured keratinocytes. Next, biochemical analyses were performed to confirm localization of PSPH and to identify candidate binding proteins. Finally, proliferation and apoptosis studies were performed in human SCC and normal keratinocytes, respectively, transduced with vectors encoding small hairpin RNAs targeting PSPH or overexpressing a phosphatase-deficient PSPH mutant. RESULTS: PSPH is expressed throughout the proliferative layer of the epidermis and hair follicles in rodent and human skin and is highly induced in SCC. In keratinocytes, PSPH is a cytoplasmic protein that primarily localizes to endosomes and is present primarily as a homodimer. Knock down of PSPH dramatically diminished SCC cell proliferation and cyclin D1 levels in the presence of exogenous of l-serine production suggesting a non-canonical role for PSPH in epithelial carcinogenesis. CONCLUSIONS: Psph is highly induced in proliferative normal keratinocytes and in skin tumors. PSPH appears to be critical for the proliferation of SCC cells; however, this phenomenon may not involve the phosphoserine metabolic pathway.
BACKGROUND:L-3-Phosphoserine phosphatase (PSPH) is a highly conserved and widely expressed member of the haloacid dehalogenase superfamily and the rate-limiting enzyme in l-serine biosynthesis. We previously found Psph expression to be uniquely upregulated in a α6β4 integrin transgenicmouse model that is predisposed to epidermal hyperproliferation and squamous cell carcinoma (SCC) formation implicating a role for Psph in epidermal homeostasis. OBJECTIVE: We examined the status of PSPH in normal skin epidermis and skin tumors along with its sub-cellular localization in epidermal keratinocytes and its requirement for squamous cell carcinoma (SCC) proliferation. METHODS: First, an immunohistochemical study was performed for PSPH in normal skin and skin cancer specimens and in cultured keratinocytes. Next, biochemical analyses were performed to confirm localization of PSPH and to identify candidate binding proteins. Finally, proliferation and apoptosis studies were performed in humanSCC and normal keratinocytes, respectively, transduced with vectors encoding small hairpin RNAs targeting PSPH or overexpressing a phosphatase-deficient PSPH mutant. RESULTS:PSPH is expressed throughout the proliferative layer of the epidermis and hair follicles in rodent and human skin and is highly induced in SCC. In keratinocytes, PSPH is a cytoplasmic protein that primarily localizes to endosomes and is present primarily as a homodimer. Knock down of PSPH dramatically diminished SCC cell proliferation and cyclin D1 levels in the presence of exogenous of l-serine production suggesting a non-canonical role for PSPH in epithelial carcinogenesis. CONCLUSIONS:Psph is highly induced in proliferative normal keratinocytes and in skin tumors. PSPH appears to be critical for the proliferation of SCC cells; however, this phenomenon may not involve the phosphoserine metabolic pathway.
Authors: A V Terskikh; M C Easterday; L Li; L Hood; H I Kornblum; D H Geschwind; I L Weissman Journal: Proc Natl Acad Sci U S A Date: 2001-07-03 Impact factor: 11.205
Authors: Sirkku Pollari; Sanna-Maria Käkönen; Henrik Edgren; Maija Wolf; Pekka Kohonen; Henri Sara; Theresa Guise; Matthias Nees; Olli Kallioniemi Journal: Breast Cancer Res Treat Date: 2010-03-30 Impact factor: 4.872
Authors: Houman D Hemmati; Ichiro Nakano; Jorge A Lazareff; Michael Masterman-Smith; Daniel H Geschwind; Marianne Bronner-Fraser; Harley I Kornblum Journal: Proc Natl Acad Sci U S A Date: 2003-11-26 Impact factor: 11.205
Authors: Boris Egger; Ronny Leemans; Thomas Loop; Lars Kammermeier; Yun Fan; Tanja Radimerski; Martin C Strahm; Ulrich Certa; Heinrich Reichert Journal: Development Date: 2002-07 Impact factor: 6.868
Authors: David J Montefusco; Benjamin Newcomb; Jason L Gandy; Sarah E Brice; Nabil Matmati; L Ashley Cowart; Yusuf A Hannun Journal: J Biol Chem Date: 2012-01-25 Impact factor: 5.157
Authors: Yalda Moayedi; Sophie A Greenberg; Blair A Jenkins; Kara L Marshall; Lina V Dimitrov; Aislyn M Nelson; David M Owens; Ellen A Lumpkin Journal: Mol Carcinog Date: 2019-01-20 Impact factor: 4.784
Authors: Iasha Z Khan; Christina A Del Guzzo; Anqi Shao; Jiyoon Cho; Rong Du; Adrienne O Cohen; David M Owens Journal: Cancer Res Date: 2021-06-28 Impact factor: 12.701